Medical Marijuana, Inc. (MJNA: OTC Pink Current) | Medical

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
[b]Medical Marijuana, Inc. (MJNA: OTC Pink Current) | Medical Marijuana Inc.'s HempMeds Title Sponsor of National Cannabis Industry Association Denver Conference[/b]

SAN DIEGO, April 15, 2014 (GLOBE NEWSWIRE) -- Medical Marijuana Inc. (OTC Pink:MJNA) is pleased to announce that its subsidiary company, HempMeds ™, is the sponsor of the National Cannabis Industry Association ( NCIA )'s NCIA "Educational Series" conference in Denver. The conference takes place on Tuesday, April 15 th at the Exdo Events Center at 1399 35 th St. Denver, Colorado 80205. The NCIA focuses on three key elements: protecting legitimate cannabis businesses, banking access for those businesses, and fair tax policy. The organization's mission is to lead a unified and coordinated effort to ensure the cannabis industry is treated fairly under federal law. The conference agenda includes an invitation-only reception, business networking, and panel discussion.



















HempMedsPX logo





"We applaud the efforts of the NCIA and their mission to ensure that responsible and legitimate cannabis-related businesses are treated fairly," states Charles Vest, VP of Communications for HempMeds ™. "As the title sponsor of the NCIA's Educational Series conference during the historic '420 week,' HempMeds ™ is showing support for all cannabis businesses in this rapidly growing and changing industry."



NCIA member businesses receive two admission tickets. Non-members who wish to attend can register online. Admission is a $75 donation per ticket. All ticket and sponsorship proceeds support the work of the National Cannabis Industry Association .



" HempMeds ™ is one of many legitimate cannabis-related businesses nationwide," Vest continues. "We are actively creating awareness about our unique CBD-rich hemp oil products so that other legitimate cannabis businesses have an opportunity to add variety to their product offerings, regardless of where they are located in the country. And we are thrilled to support an inclusive organization like the NCIA that understands and supports responsible companies invested in cannabis, whether hemp or marijuana."



For more information on CBD-rich hemp oil products, please visit:



HempMeds ™



http://www.HempMeds.com



866.273.8502



Real Scientific Hemp Oil ™



http://RealScientificHempOil.com



866.273.8502



Cibdex™



http://www.cibdex.com



866.273.8502



Cibaderm ™



http://www.cibaderm.com



866.273.8502



The Company invites the public to get involved in the conversation about CBD-rich hemp oil as it relates to HempMeds ™ through the Company's social media websites on Facebook and Twitter .



About HempMeds



HempMeds ™ offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds ™ is a corporate portfolio company of  Medical Marijuana, Inc.  (OTC Pink:MJNA) and the Company's exclusive master distributor and contracted marketing company. In addition to handling sales and distribution,  HempMeds ™ is the communication hub for the Medical Marijuana Inc. portfolio of companies.



About Medical Marijuana Inc.



Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company's website at: www.MedicalMarijuanaInc.com



FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE



These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.



FORWARD-LOOKING DISCLAIMER



This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana Inc. to be materially different from the statements made herein.



LEGAL DISCLOSURE



Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


 CONTACT: For further information, please contact: 

Investor relations contact:
Perry Coleman
Medical Marijuana, Inc.
P. 443-453-5088
perry@medicalmarijuanainc.com

Corporate contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc



Medical Marijuana Inc Logo

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 407

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
DKSH's Vietnam Oncology Pact Carries Real Promise, Risk

Updated Category News Views 119

A cancer-market announcement ought to make investors pause before they reach for a spreadsheet. Specialised Therapeutics and DKSH have signed an exclusive partnership to bring oncology therapies into Vietnam, and the human case is painfully clear: the country recorded an estimated 180,000 new cancer cases and more than 120,000 deaths annually in the 2022 GLOBOCAN data....

Continue Reading
Luca's Campo Morado Denial Makes Guerrero Risk Clear

Updated Category News Views 94

A Dangerous Headline Needs More Than a Quick Rebuttal One ugly allegation can do more damage to a junior miner than a lousy quarter, especially when it involves a mine in Guerrero State and alleged criminal control. Luca Mining has flatly rejected Mexican media reports claiming that its Campo Morado Mine is controlled by a criminal organization. The company says the...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 292

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 481

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Australia Leads TTW's 2027 Global Travel Country List

Updated Category News Views 75

A travel ranking is a map, not a balance sheet, and that distinction matters more than the glossy numbering. TTW has put Australia at the head of its editorial list of the 50 best countries to visit in 2027, followed by Switzerland, Japan, Canada and Thailand. Fair enough. Those are formidable tourism brands with the scenery, infrastructure and cultural pull to back up...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 570

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 478

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 91

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 130

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading

Top 5 Most Recently Viewed Articles

Trump Ventures into Cryptocurrency: A Challenging Transition

Updated Category News Views 79

Trump's Shift Towards Cryptocurrency In an unexpected move, Donald Trump has made headlines by stepping into the cryptocurrency market. This shift has drawn both curiosity and skepticism, especially since Trump had previously labeled Bitcoin as a "scam." Many are now questioning if he truly understands the intricacies of the cryptocurrency world he now supports. World...

Continue Reading
IPG Photonics Announces Upcoming Financial Results Event

Updated Category News Views 147

IPG Photonics Scheduled to Release Third Quarter Results IPG Photonics Corporation (Nasdaq: IPGP) is poised to announce its third quarter financial results on November 4, 2025. This event is anticipated to shed light on the Company’s performance and future outlook. Before the market opens that day, IPG will share its financial results, providing investors and...

Continue Reading
Willdan Group Achieves Significant Growth with New Projects

Updated Category News Views 49

Willdan Group Soars to New Heights Willdan Group Inc. (NASDAQ: WLDN) recently celebrated a remarkable achievement as its stock soared to a 52-week high of $41.58. This milestone is not just a number; it represents the confidence that investors have in the company, showcasing a tremendous 109.11% increase in its stock price over the last year. Such significant growth...

Continue Reading
International Paper's Commitment to Shareholders Deepens with Dividends

Updated Category News Views 108

International Paper's Quarterly Dividend Announcement International Paper (NYSE: IP) has reaffirmed its dedication to its shareholders with the announcement of substantial quarterly dividends. Recently, the company declared a dividend of $0.4625 per share, covering the period from the start of January to the end of March of this year. This payment reflects the...

Continue Reading